Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link

Zhang, Ying, Huang, Nan-qu, Yan, Fei, Jin, Hai, Zhou, Shao-yu, Shi, Jing-shan, Jin, Feng·2018·Behavioural Brain Research

DOI 10.1016/j.bbr.2017.11.015

Cited by (298)

Items 101–200 of 298

Exploring the Antidiabetic Potential of Salvia officinalis Using Network Pharmacology, Molecular Docking and ADME/Drug-Likeness Predictions
Chimaobi James Ononamadu, Véronique Seidel · 2024 · Plants
Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease
Feng-Qing Xu, Jingshan Shi · 2025 · Journal of Alzheimer s Disease
Type 3 diabetes (Alzheimer's disease): new insight for promising therapeutic avenues
Mayuren Candasamy, Safa Abdelgadir Mohamed Elhassan, Subrat Kumar Bhattamisra, Wong Y Hua, Lim M Sern, Nurul A Binti Busthamin, Nurmaisaratulain B Mohamad Ilni, Ng S Shun, Lim Baohong, Ng S Ya et al. · 2020 · Panminerva Medica
Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
Adrianna Wysocka, Ewelina Pałasz, Marta Steczkowska, Grażyna Niewiadomska · 2020 · Current Alzheimer Research
Investigation for GSK3β expression in diabetic osteoporosis and negative osteogenic effects of GSK3β on bone marrow mesenchymal stem cells under a high glucose microenvironment
Yu Chen, Long Chen, Runyu Huang, Wenyue Yang, Siyue Chen, Kaili Lin, Jiaqiang Liu · 2020 · Biochemical and Biophysical Research Communications
Decreased miR-132 plays a crucial role in diabetic encephalopathy by regulating the GSK-3β/Tau pathway
Li Shi, Rui Zhang, Tian Xiang Li, Xue Han, Nannan Yuan, Lei Jiang, Huimin Zhou, Shunjiang Xu · 2020 · Aging
NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer’s Disease
Yulia K. Komleva, Ilia Potapenko, Olga L. Lopatina, Yana V. Gorina, Anatoly Chernykh, Е. Д. Хилажева, Alla Borisovna Salmina, Аnton N. Shuvaev · 2021 · International Journal of Molecular Sciences
Catalpol Ameliorates Neurotoxicity in N2a/APP695swe Cells and APP/PS1 Transgenic Mice
Jikun Du, Jierong Liu, Xiaoman Huang, Yuanhua Li, Daibo Song, Qin Li, Jiantao Lin, Baohong Li, Li Li · 2022 · Neurotoxicity Research
Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase
Ai Sze Wee, Thao Dinh Nhu, Kooi Yeong Khaw, Kim San Tang, Keng Yoon Yeong · 2022 · Current Neuropharmacology
A Comprehensive Review of the Effects of Glycemic Carbohydrates on the Neurocognitive Functions Based on Gut Microenvironment Regulation and Glycemic Fluctuation Control
Yin Jian, Li Cheng, Yan Hong, Zhaofeng Li, Caiming Li, Xiaofeng Ban, Ling Zhu, Zhengbiao Gu · 2023 · Nutrients
Seipin deletion in mice enhances phosphorylation and aggregation of tau protein through reduced neuronal PPARγ and insulin resistance
H.C. Chang, Tingting Di, Ya Wang, Xianying Zeng, Guoxi Li, Qi Wan, Wenfeng Yu, Ling Chen · 2019 · Neurobiology of Disease
Icariin protects against sodium azide—induced neurotoxicity by activating the PI3K/Akt/GSK-3β signaling pathway
Ying Zhang, Nanqu Huang, Hao Lu, Juan Huang, Hai Dan Jin, Jingshan Shi, Feng Jie Jin · 2020 · PeerJ
Omarigliptin/galangin combination mitigates lipopolysaccharide-induced neuroinflammation in rats: Involvement of glucagon-like peptide-1, toll-like receptor-4, apoptosis and Akt/GSK-3β signaling
Ahmed M. Kabel, Hany H. Arab, Aliaa Atef, Remon S. Estfanous · 2022 · Life Sciences
Neuroprotective effect of salidroside on hippocampal neurons in diabetic mice via PI3K/Akt/GSK-3β signaling pathway
Xuehua Wang, Zhongfu Zuo, Lu Meng, Qi Yang, Pan Lv, Lipan Zhao, Xiao-Bai Wang, Yufei Wang, Ying Kao Huang, Cong Fu et al. · 2023 · Psychopharmacology
Baicalein Ameliorates Insulin Resistance of HFD/STZ Mice Through Activating PI3K/AKT Signal Pathway of Liver and Skeletal Muscle in a GLP-1R-Dependent Manner
Na Liu, Xin Cui, Tingli Guo, Xiaotong Wei, Yuzhuo Sun, Jieyun Liu, Yangyang Zhang, Wei-Na Ma, Wenhui Yan, Li-Na Chen · 2024 · Antioxidants
LC-Q-TOF-MS Characterization of Polyphenols from White Bayberry Fruit and Its Antidiabetic Effect in KK-Ay Mice
Yilong Liu, Xianan Zhang, Liuhuan Zhan, Chang Xu, Linxiao Sun, Huamin Jiang, Chongde Sun, Xian Li · 2020 · ACS Omega
Emerging role of Metformin in Alzheimer’s disease: A translational view
Juvenal A. Ríos, Juan Carlos Bórquez, Juan Alejandro Godoy, Juan Manuel Zolezzi, María Cristina Furrianca, Nibaldo C. Inestrosa · 2024 · Ageing Research Reviews
Berberine Ameliorates Cognitive Disorder via GSK3β/PGC-1α Signaling in APP/PS1 Mice
Meng Yang, Jing Wang · 2022 · Journal of Nutritional Science and Vitaminology
Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease
Xia, Zhao-Di, Ma, Ruo-Xin, Wen, Jin-Feng, Zhai, Yu-Fei, Wang, Yu-Qi, Wang, Feng-Yun, Liu, Dan, Zhao, Xiao-Long, Sun, Bao, Jia, Pu et al. · 2023 · Journal of Alzheimer's Disease
The Conceivable Role of Metabolic Syndrome in the Pathogenesis of Alzheimer’s Disease: Cellular and Subcellular Alterations in Underpinning a Tale of Two
Ekremah A Alzarea, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Athanasios T. Alexiou, Marios Papadakis, Olivia N. Beshay, Gaber El‐Saber Batiha · 2025 · NeuroMolecular Medicine
Early intervention with gastrodin reduces striatal neurotoxicity in adult rats with experimentally‑induced diabetes mellitus
Yu‐Han Qi, Rui Zhu, Qing Wang, Qian Li, Yidan Liu, Zhongyi Qian, Zhi‑Hong Yang, Zhihao Mu, Xin‐Jie Liu, Mei‐Yan Zhang et al. · 2019 · Molecular Medicine Reports
Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway
Lihong Chen, Min Jian Xu, Wenting Zhong, Yinghui Hu, Guanghui Wang · 2020 · Experimental Cell Research
Is diabetes associated with increased pathological burden in Alzheimer's disease?
Kaviyon Sadrolashrafi, Suzanne Craft, Boris Decourt, Abdu Adem, Jeffrey R. Wilson, Justin Miller, Marwan Noel Sabbagh · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Indole Compound NC009-1 Augments APOE and TRKA in Alzheimer’s Disease Cell and Mouse Models for Neuroprotection and Cognitive Improvement
Yi-Chun Chen, Ya‐Jen Chiu, Chih‐Hsin Lin, Wen‐Chuin Hsu, Jia-Lu Wu, Chen-Hsiang Huang, Chia-Wei Lin, Ching‐Fa Yao, Hei-Jen Huang, Yen‐Shi Lo et al. · 2019 · Journal of Alzheimer s Disease
3×Tg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-β Production and Tau Hyperphosphorylation
Wen-Zhi Wang, Mingwei Li, Ying Chen, Liyuan Liu, Yong Xu, Zeng-Hui Xia, Yang Yu, Xiaodan Wang, Wei Chen, Feng Zhang et al. · 2021 · Journal of Alzheimer s Disease
Insulin receptor preserves mitochondrial function by binding VDAC1 in insulin insensitive mucosal epithelial cells
Rossella Titone, Danielle M. Robertson · 2019 · The FASEB Journal
Transcending the amyloid-beta dominance paradigm in Alzheimer's disease: An exploration of behavioural, metabolic, and gut microbiota phenotypes in 5xFAD mice
Dina Medina Vera, Emma N. Zambrana-Infantes, Antonio J. López-Gambero, Julia Verheul-Campos, Luis J. Santín, Elena Baixerás, Juan Suárez, Francisco Javier Pavón, Cristina Rosell‐Valle, Fernando Rodrı́guez de Fonseca · 2023 · Neurobiology of Disease
1,3,4-Oxadiazole Scaffold in Antidiabetic Drug Discovery: An Overview
Ojasvi Gupta, Gita Chawla, Tathagata Pradhan · 2024 · Mini-Reviews in Medicinal Chemistry
Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice
Hei-Jen Huang, Shu-Ling Chen, Hsin‐Yu Huang, Ying‐Chieh Sun, Guan-Chiun Lee, Guey‐Jen Lee‐Chen, Hsiu Mei Hsieh‐Li, Ming‐Tsan Su · 2018 · Psychopharmacology
Nanotechnology Advances Proteolysis Targeting Chimeras (PROTACs): Transition From Basic Research to Clinical Application
Xupeng Mu, Chongqiang Mu, Mengxue Wang, Meng Chen, Huimin Liu, Haibin Lu · 2025 · International Journal of Nanomedicine
Phytotherapy in Alzheimer’s Disease—A Narrative Review
Julia Piekarz, Natalia Picheta, Oliwia Burdan, Marcelina Kurek, Magdalena Chrościńska–Krawczyk · 2024 · Biomedicines
The Role of MAPK's Signaling in Mediating ApoE4-Driven Pathology In Vivo
Shiran Salomon‐Zimri, Amit Koren-Iton, Ariel Angel, Tali Ben‐Zur, Daniel Offen, Daniel M. Michaelson · 2019 · Current Alzheimer Research
Liraglutide Treatment Ameliorates Neurotoxicity Induced by Stable Silencing of Pin1
Marzia Bianchi, Valentina Doria, Maria Rita Braghini, Stefania Petrini, Melania Manco · 2019 · International Journal of Molecular Sciences
Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1
Xiao‐Yu Liu, Ni Zhang, Sheng‐Xiao Zhang, Ping Xu · 2021 · European Journal of Neuroscience
Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo
Guo-Liang Yin, Hong-Yi Liang, Wen-Xiu Sun, Shi-Zhao Zhang, Ya-Nan Feng, Pengpeng Liang, Su-Te Chen, Xiangyi Liu, Wenchao Pan, Feng-Xia Zhang · 2022 · Frontiers in Pharmacology
Clinical antidiabetic medication used in Alzheimer’s disease: From basic discovery to therapeutics development
Juan Huang, Nanqu Huang, Di Cui, Jingshan Shi, Yu Qiu · 2023 · Frontiers in Aging Neuroscience
Synthesis and activities of acetylcholinesterase inhibitors
Shiyang Zhou, Gangliang Huang · 2021 · Chemical Biology & Drug Design
Association between insulin and Nrf2 signalling pathway in Alzheimer's disease: A molecular landscape
Syed Obaidur Rahman, Tahira Moeen Khan, Ashif Iqubal, Shivani Agarwal, Mohd Akhtar, Suhel Parvez, Zahoor Ahmad Shah, Abul Kalam Najmi · 2023 · Life Sciences
Identification of genes related to glucose metabolism and analysis of the immune characteristics in Alzheimer's disease
Yina Wang, Zhouji Shen, Hao Wu, Zefeng Yu, Xiping Wu, Libin Zhou, Fei Guo · 2023 · Brain Research
A computational model of Alzheimer's disease at the nano, micro, and macroscales
Éléonore Chamberland, Seyedadel Moravveji, Nicolas Doyon, Simon Duchesne · 2024 · Frontiers in Neuroinformatics
Neurotherapeutic effects of quercetin-loaded nanoparticles and Biochanin-A extracted from Trifolium alexandrinum on PI3K/Akt/GSK-3β signaling in the cerebral cortex of male diabetic rats
Al‐Sayeda A. Newairy, Fatma A. Hamaad, Mayssaa M. Wahby, Mamdooh Helal Ghoneum, Heba Mohamed Abdou · 2024 · PLoS ONE
Down-regulation of betatrophin enhances insulin sensitivity in type 2 diabetes mellitus through activation of the GSK-3β/PGC-1α signaling pathway
Q. Hao, A. Zheng, H. Zhang, Hui Cao · 2021 · Journal of Endocrinological Investigation
Periphery Biomarkers for Objective Diagnosis of Cognitive Decline in Type 2 Diabetes Patients
Yanchao Liu, Shujuan Zhang, Benrong He, Liangkai Chen, Dan Ke, Shi Zhao, Yao Zhang, Wei Wei, Zhipeng Xu, Zihui Xu et al. · 2021 · Frontiers in Cell and Developmental Biology
Pharmacodynamics, Network Pharmacology, and Pharmacokinetics of Chinese Medicine Formula 9002A in the Treatment of Alzheimer’s Disease
Chunlan Tang, Zhiling Fang, Donghui Chu, Lulu Zhang, Yuqing Tang, Jinyue Zhou, Rui Fang, Jiaming Ying, Fang Wang, Yuping Zhou et al. · 2022 · Frontiers in Pharmacology
Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?
Cassandra M. Flynn, Qi Yuan · 2023 · Frontiers in Neuroscience
Glycogen synthase kinase (GSK)-3 and the double-strand RNA-dependent kinase, PKR: When two kinases for the common good turn bad
Manuela Piazzi, Alberto Bavelloni, Irene Faenza, William L. Blalock · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Neuroprotective substances: Are they able to protect the pancreatic beta-cells too?
Ostrovskaya, Rita U., Ivanov, Sergei V. · 2022 · Endocrine, Metabolic & Immune Disorders - Drug Targets
Metal-polyphenol microgels for oral delivery of puerarin to alleviate the onset of diabetes
Sihui Li, Yanfei Li, Di Wu, Yu Xu, Huijia Yan, Jiangning Hu · 2023 · Drug Delivery and Translational Research
Metformin effectively alleviates the symptoms of Alzheimer in rats by lowering amyloid β deposition and enhancing the insulin signal
Hamed A. Abosharaf, Yasmin Elsonbaty, Ehab Tousson, Tarek Mostafa Mohamed · 2024 · Metabolic Brain Disease
Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer’s Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer’s Disease
Subham Das, Anu Kunnath Ramachandran, Debojyoti Halder, Saleem Akbar, Bahar Ahmed, Alex Joseph · 2022 · CNS & Neurological Disorders - Drug Targets
Diabetes Mellitus and Energy Dysmetabolism in Alzheimer’s Disease: Understanding the Relationships and Potential Therapeutic Targets
Adejoke Y. Onaolapo, Folusho O. Ojo, Olufunto Omodele Adeleye, Joshua Falade, Olakunle J. Onaolapo · 2023 · Current Diabetes Reviews
Advances in targeting glycogen synthase kinase 3β for diabetes therapy
Fuyu Wang, Yating Li, Lan Bai, Wen‐Jing Xiao, Ling Zhong, Jianyou Shi · 2025 · Bioorganic Chemistry
Downregulation of GSK-3β Expression via Ultrasound-Targeted Microbubble Destruction Enhances Atherosclerotic Plaque Stability in New Zealand Rabbits
Lifei Yang, Lingzi Chen, Fang Ye, Suya Ma · 2020 · Ultrasound in Medicine & Biology
New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer’s disease
Sweta Priyadarshini Pradhan, Pratap Kumar Sahu, Anindita Behera · 2023 · Molecular and Cellular Biochemistry
Micropeptides: origins, identification, and potential role in metabolism-related diseases
Yirui Lu, Yutong Ran, Hong Li, Jiao Wen, Xiaodong Cui, Xiaoyun Zhang, Xiumei Guan, Min Cheng · 2023 · Journal of Zhejiang University SCIENCE B
Dendrobium nobile Lindl. alkaloid decreases Tau hyperphosphorylation via regulating PI3K/Akt/GSK-3β pathway in vitro and in vivo
Juan Huang, Nanqu Huang, Yu Lan Qiu, Jingshan Shi · 2023 · Journal of Ethnopharmacology
GSK3β : A ray of hope for the treatment of diabetic kidney disease
Lulu Liang, Mengfei He, Pan‐Pan Zhou, Shaokang Pan, Dongwei Liu, Zhangsuo Liu · 2024 · The FASEB Journal
AdipoRon Ameliorates Synaptic Dysfunction and Inhibits tau Hyperphosphorylation through the AdipoR/AMPK/mTOR Pathway in T2DM Mice
Wenyan Zhao, Wei Yan Zhang, Yingying Hu, Yuliang Zhou, Jinying Zhao, Yahong Li, Zhipeng Xu · 2024 · Neurochemical Research
Alzheimer's disease, a metabolic disorder: Clinical advances and basic model studies (Review)
Shanhu Zhou, Limin Tu, Wei Chen, Gangli Yan, Hongmei Guo, Xinhua Wang, Qian Hu, Huiqing Liu, Fengguang Li · 2023 · Experimental and Therapeutic Medicine
Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes?
Marzia Bianchi, Melania Manco · 2018 · International Journal of Molecular Sciences
Natural coumarins as anti-diabetic agents: Mechanisms, therapeutic potential, and amelioration of diabetic complications
Shahnaaz Khatoon, Raabia Naaz, Umam Khan, Fayeqa Qayyum, Shakir Ahamad, Mohammad Saquib, Mohd Kamil Hussain · 2025 · Phytomedicine
In Vivo and Computational Studies on Sitagliptin’s Neuroprotective Role in Type 2 Diabetes Mellitus: Implications for Alzheimer’s Disease
Vasudevan Mani, Minhajul Arfeen · 2024 · Brain Sciences
Aging-dependent YAP1 reduction contributes to AD pathology by upregulating the Nr4a1-AKT/GSK-3β axis
Ling Lei, Yilei Cheng, Anqi Yin, Jian-Min Han, Gang Wu, Fumin Yang, Qi Wang, Jian‐Zhi Wang, Rong Liu, Honglian Li et al. · 2025 · Translational Neurodegeneration
Screening Traditional Chinese Medicine Combination for Cotreatment of Alzheimer’s Disease and Type 2 Diabetes Mellitus by Network Pharmacology
Yizhen Wang, Lei Meng, Qi‐Shuai Zhuang, Liang Shen · 2021 · Journal of Alzheimer s Disease
The molecular mechanisms of signal pathway activating effect of E2F-1/NF-κB/GSK-3β on cognitive dysfunction of Alzheimer rats
Mayila Tuerxun, Ajar Muhda, Lixin Yin · 2021 · Bioengineered
Dementia in diabetes mellitus and atherosclerosis: Two interrelated systemic diseases
Parvaneh Mohseni Moghaddam, Roshanak Ghobadian, Hossein Khaleghzadeh‐Ahangar · 2022 · Brain Research Bulletin
Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations
Triana Espinosa-Jiménez, Oriol Busquets, Amanda C. Cano, Elena Sánchez‐López, Ester Verdaguer, Antoni Parcerisas, Jordi Olloquequi, Carme Auladell, Jaume Folch, Walter Wahli et al. · 2022 · Frontiers in Pharmacology
Influence of Exercise and Genistein to Mitigate the Deleterious Effects of High-Fat High-Sugar Diet on Alzheimer’s Disease-Related Markers in Male Mice
Juhi Shah, Tyler Orosz, Avneet Singh, Savan Parameshwar Laxma, R Gross, Nicholas Smith, Spencer A. Vroegop, Sydney R. Sudler, James T. Porter, Maria Colon et al. · 2024 · International Journal of Molecular Sciences
A Narrative Review on Cognitive Impairment in Type 2 Diabetes: Global Trends and Diagnostic Approaches
Xiaobin Liao, Yibin Zhang, Jialu Xu, Jiaxin Yin, Shan Li, Kun Dong, Xiaoli Shi, Weijie Xu, Delin Ma, Xi Chen et al. · 2025 · Biomedicines
Interlinking diabetes and Alzheimer's disease: A pathway through medicinal plant-based treatments
Sandesh Kumar Pattanaik, Prajapati Manisha Anil, Sudipta Jena, Diptirani Rath · 2025 · Journal of Ethnopharmacology
The Multi-Dimensional Action Map of Resveratrol Against Alzheimer’s Disease: Mechanism Integration and Treatment Strategy Optimization
Yichen Liu, Yadan Dong, Zhen Cao, Yixuan Ji, Xiaoxin Cheng, Xu Zheng · 2025 · Nutrients
AT1R/GSK-3β/mTOR Signaling Pathway Involved in Angiotensin II-Induced Neuronal Apoptosis after HIE Both In Vitro and In Vivo
Si Wei, Banghui Li, Cameron Lenahan, Shirong Li, Ran Gu, Hao Qu, Lu Wang, Jiapeng Liu, Tian Tian, Qian Wang et al. · 2020 · Oxidative Medicine and Cellular Longevity
Extra-cranial factors in the development of Alzheimer’s disease
Arnold R. Eiser, Tamàs Fülöp · 2020 · Brain Research
2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione Ameliorates Diabetic Cognitive Impairment Through Inhibiting Hif3α and Apoptosis
Lihui Wang, Jinjin Cao, Qianqian Xu, Xiaomei Lu, Xin Yang, Qiong Song, Shuai Chen, Kechen Du, Renbin Huang, Chunlin Zou · 2021 · Frontiers in Pharmacology
Explore the Mechanism of β-Asarone on Improving Cognitive Dysfunction in Rats with Diabetic Encephalopathy
Jingwen Cai, Ming Cai, Wenwen Xia, Lanlan Jiang, Hang Song, Xiang-Tao Chen · 2022 · Journal of Alzheimer s Disease Reports
Study on Undercarboxylated Osteocalcin in Improving Cognitive Function of Rats with Type 2 Diabetes Mellitus by Regulating PI3K-AKT-GSK/3β Signaling Pathwaythrough medical images
Yu Zhao, Lili Yang, Mei Chen, Feng Gao, Yinghui Lv, Xue Li, Hong‐Min Liu · 2023 · Biotechnology and Genetic Engineering Reviews
Ser/Thr phosphatases: One of the key regulators of insulin signaling
Yamini Yadav, Chinmoy Sankar Dey · 2022 · Reviews in Endocrine and Metabolic Disorders
P25/CDK5-mediated Tau Hyperphosphorylation in Both Ipsilateral and Contralateral Cerebra Contributes to Cognitive Deficits in Post-stroke Mice
Jing Hua Yu, Yang Zhao, Xiaokang Gong, Zheng Liang, Yanna Zhao, Xin Li, Yu‐Ju Chen, Youhua Yang, Mengjuan Wu, Xiaochuan Wang et al. · 2023 · Current Medical Science
Role of ceramides in diabetic foot ulcers (Review)
Ying Wang, Zhen Sun, Guangyao Zang, Lili Zhang, Zhongqun Wang · 2023 · International Journal of Molecular Medicine
Mechanisms underlying large-leaf yellow tea mediated inhibition of cognitive impairment in the 5xFAD model of Alzheimer's disease
Xiaoyu Tang, Zhipeng Kan, Na Li, Jinbao Huang, Jinsong Zhang, Henry J. Thompson, Feng Gao, Yong Shen, Liang Zhang, Zhongwen Xie et al. · 2023 · Phytomedicine
Exploring resveratrol against Alzheimer's disease and Parkinson's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vitro
Jinpu Wu, Ziyue Tian, Boxue Wang, Jian Liu, Ran Bi, Naixin Zhan, Daixuan Song, Chengcheng He, Weimin Zhao · 2024 · Heliyon
Quo vadis PGRMC? Grand-Scale Biology in Human Health and Disease
Michael A. Cahill · 2022 · Frontiers in Bioscience-Landmark
Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study
Gemma García‐Lluch, Carmen Peña‐Bautista, Lucrecia Moreno, Miguel Baquero, Antonio José Cañada Martínez, Consuelo Cháfer‐Pericás · 2023 · Pharmaceutics
e-QSAR (Explainable AI-QSAR), molecular docking, and ADMET analysis of structurally diverse GSK3-beta modulators to identify concealed modulatory features vindicated by X-ray
Vijay Hariram Masand, Sami A. Al‐Hussain, Gaurav S. Masand, Abdul Samad, Rakhi G. Gawali, Shravan Jadhav, Magdi E. A. Zaki · 2024 · Computational Biology and Chemistry
Hypoglycemic activity of loquat seeds polysaccharide in insulin resistant HepG2 cells
Shiyang Zhou, Jun Tan · 2025 · Journal of Food Measurement & Characterization
Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics
Yongjun Cao, Han-Zhou Li, Jie Zhao, Yumeng Sun, Xiao-Wen Jin, Shuquan Lv, Jun-Yu Luo, Xixing Fang, Weibo Wen, Jiabao Liao · 2022 · Evidence-based Complementary and Alternative Medicine
Tau aggravates stress-induced anxiety by inhibiting adult ventral hippocampal neurogenesis in mice
Hao Liu, Zhi Yang, Chunyan Yu, Hao Dong, Shiyan Wang, Gang Wang, Denian Wang · 2022 · Cerebral Cortex
Insights on the pathogenesis of type 2 diabetes as revealed by signature genomic classifiers in an African American population in the Washington, DC area
Tanmoy Mondal, Christopher A. Loffredo, Jyothirmai J. Simhadri, Gail Nunlee‐Bland, Brent A. Korba, Jheannelle Johnson, Sharleine T. Cotin, Gemeyel Moses, Ruth I. Quartey, Charles D. Howell et al. · 2022 · Diabetes/Metabolism Research and Reviews
PP1γ regulates neuronal insulin signaling and aggravates insulin resistance leading to AD-like phenotypes
Yamini Yadav, Medha Sharma, Chinmoy Sankar Dey · 2023 · Cell Communication and Signaling
Traditional Chinese medicine in Alzheimer's disease: From the perspective of GSK-3β and Tau hyperphosphorylation
Mei Wang, Wendi Huang, Juan Huang, Jingshan Shi, Nanqu Huang, Yong Luo · 2024 · Pharmacological Research - Modern Chinese Medicine
The attenuation effect of potassium 2‐(1‐hydroxypentyl)‐benzoate in a mouse model of diabetes‐associated cognitive decline: The protein expression in the brain
Wenwen Yu, Hua‐Jing Yin, Yingni Sun, Si Shi, Jiang Li, Xiao‐Liang Wang · 2022 · CNS Neuroscience & Therapeutics
Intracerebroventricular streptozotocin-induced animal model of Alzheimer’s disease: revealing dose optimization, administration regimen, and molecular pathways
Sagar Arun More, Radhika N. Mundke, Yogeeta O. Agrawal, Sanjay N. Awathale, Sameer N. Goyal, Kartik Tularam Nakhate, Sumit S. Rathod · 2026 · Laboratory Animal Research
Metabolism toxicity and susceptibility of decabromodiphenyl ether (BDE-209) exposure on BRL cells with insulin resistance
Guanghua Mao, Junjie Tang, Taotao Liao, Xiaoxiang Shi, FangYuan Dong, Weiwei Feng, Yao Chen, Ting Zhao, Xiangyang Wu, Liuqing Yang · 2022 · Environmental Science and Pollution Research
BACE1 Inhibition Protects Against Type 2 Diabetes Mellitus by Restoring Insulin Receptor in Mice
Tingting Lin, Ting Xin Liang, Yong Shen, Feng Gao · 2025 · International Journal of Molecular Sciences
Molecular docking study of xylogranatins binding to glycogen synthase kinase-3β
Christian Bailly, Gérard Vergoten · 2022 · Digital Chinese Medicine
Knockdown of CLC-3 may improve cognitive impairment caused by diabetic encephalopathy
Jingxuan Lian, Litian Ma, Yanyang Tu, Jianfang Fu · 2022 · Diabetes Research and Clinical Practice
Kinase inhibition in Alzheimer’s disease
Soghra Bagheri, Ali Akbar Saboury · 2022 · Elsevier eBooks
Metabolic Profile of Alzheimer’s Disease: Is 10-Hydroxy-2-decenoic Acid a Pertinent Metabolic Adjuster?
Yuan Gong, Hongjie Luo, Zeju Li, Yijun Feng, Zhen Liu, Jie Chang · 2023 · Metabolites
Skimmin Improves Insulin Resistance via Regulating the Metabolism of Glucose: In Vitro and In Vivo Models
Guo-Qiang Zhang, Xin Cai, Lingmin He, Dingmei Qin, Hongwen Li, Xiaoming Fan · 2020 · Frontiers in Pharmacology
Dietary berberine ameliorates glucose metabolism by regulating the FXR pathway in largemouth bass (Micropterus salmoides)
Hui-Ci Yang, Guang-Jun Wang, Yun Long Xia, Jingjing Tian, Jun Hua Xie, Kai Zhang, Zhifei Li, Ermeng Yu, Hong-Yan Li, Wangbao Gong et al. · 2024 · Aquaculture Reports